In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews, March 2014

Executive Summary

This Month's Profile Group, Start-Ups Reduce Radiation Exposure, features profiles of ControlRad Systems, Nanovi, and SoniTrack Systems. Plus these Start-Ups Across Health Care: Mardil Medical, MedLumics, Mnemosyne Pharmaceuticals, and OxSonics.

You may also be interested in...

MedLumics SL

MedLumics SL aims to capitalize on the growing market for non-melanoma skin cancer diagnosis with the first truly handheld device that uses light-based technology for diagnostic 3-D imaging. The start-up’s device comes in a mobile format and has a handheld imaging probe that contains three imaging modalities: optical coherence tomography, epiluminescent microscopy, and a miniaturized clinical camera.

Mardil Medical Inc.

Mardil Medical Inc.’s VenTouch System for treating functional mitral valve regurgitation is intended to reshape and correct the geometry of the dilated heart, reduce or eliminate mitral valve regurgitation, and reduce heart wall stressors, all leading to a beneficial reverse remodeling effect.

Start-Ups Reduce Radiation Exposure

The use of cancer radiation therapy and interventional fluoroscopy is expanding rapidly, and start-ups are pioneering innovative technologies to capitalize on the industry-wide movement to reduce radiation exposure and improve outcomes. Profiles of ControlRad Systems, Nanovi, and SoniTrack Systems.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts